CVS Stock Is Soaring. A Director Bets $2 Million on the Rally.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Corporate America’s real worries about Trump are buried in annual reports
Yet the same day, CVS filed its annual report to shareholders with a new paragraph about “uncertainty” around changing health ...